We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 136

The General Court of the EU overturns the two European Commission lignite decisions
  • Hogan Lovells
  • European Union, Greece
  • October 31 2012

In two landmark rulings on 20 September 2012, the General Court of the European Union in Luxembourg annulled the two European Commission decisions on the Greek “lignite” case


Syfait II
  • NautaDutilh
  • European Union, Greece
  • September 17 2008

Yesterday, the EC Court of Justice (ECJ) handed down its long awaited judgment in the Syfait II Case (Joined Cases C-46806 - C-47806, Sot. Lélos kai Sia), which deals with stock management in the pharmaceutical sector


Parallel trade in medicines: ECJ judgment in the second reference re: GlaxoSmithKline’s supply policy in Greece and abuse of dominant position
  • Bird & Bird
  • European Union, Greece
  • October 16 2008

In the second reference to the European Court of Justice arising out of GSK’s policy of selling medicines directly to Greek hospitals and pharmacies the ECJ has held (Joined Cases C-46806 to C-47806 Sot. Lelos kai Sia and Others) that an undertaking which occupies a dominant position on the relevant market for medicinal products is abusing its dominant position contrary to Article 82 EC if, in order to stop parallel exports, it refuses to meet “ordinary orders” from wholesalers


ECJ delivers long-awaited judgment in Glaxo ‘Greek’ Case on parallel imports
  • Hogan Lovells
  • European Union, Greece
  • September 22 2008

On September 16, 2008, the European Court of Justice (ECJ) handed down a long-awaited judgment in Sot Lélos kai Sia EE and Others v. GlaxoSmithKline AEVE Farmakeftikon Proïonton1 (the Greek Glaxo Case


Antitrust and competition - the EU weekly briefing (14 March 2016)
  • Winston & Strawn LLP
  • Denmark, European Union, France, Greece, United Kingdom
  • March 14 2016

Commission approves McKesson acquisition of UDG Healthcare in the EEA but refers UK element to the CMA for approval. On 4 March 2016


Antitrust, competition and economic regulation client quarterly newsletter
  • Hogan Lovells
  • China, European Union, Greece, USA
  • January 24 2012

A public company CEO recently consented to a federal district court order requiring him to pay a $500,000 civil penalty for violating the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”


Antitrust and Competition - The EU Weekly Briefing (17 October 2016)
  • Winston & Strawn LLP
  • European Union, Greece, Slovenia, South Korea, United Kingdom
  • October 17 2016

On 13 October 2016 the European Commission (Commission) appealed the World Trade Organisation (WTO) ruling (which can be found here and here


Application of competition law to public bodies - recent ECJ authority
  • Shepherd and Wedderburn LLP
  • European Union, Greece
  • April 3 2008

In the first case, an independent Greek motor sport organiser challenged the decision of ELPA to refuse consent for an event it wanted to organise


AG gives Opinion in pharmaceutical parallel trade case
  • Nabarro LLP
  • European Union, Greece
  • April 16 2008

On 1 April 2008, Advocate-General Colomer (AG) gave his Opinion, on a reference from a Greek court, on whether a refusal by a dominant pharmaceutical company to meet the full orders of wholesalers amounted to an abuse of a dominant position contrary to Article 82 of the EC Treaty


GlaxoSmithKline infringed competition rules by restricting parallel trade
  • McDermott Will & Emery
  • European Union, Greece
  • April 4 2008

Advocate General Ruiz-Jarabo has delivered a non-binding opinion to the European Court of Justice (ECJ), finding that GlaxoSmithKline Plc (GSK) abused its dominant position by limiting distribution of certain pharmaceuticals to Greek wholesalers